Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001415889-24-021460

PRESIDENT AND CEO sold 15,625 shares at $37.56 ($586,927)

  • PRESIDENT AND CEO acquired 15,625 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fordyce Marshall PRESIDENT AND CEO 2024-08-14 Option exercise 10b5-1 +15,625 $2.90 $45,263 352,763 D: show line 1 in the form
Fordyce Marshall PRESIDENT AND CEO 2024-08-14 Sale 10b5-1 −15,625 $37.56 $586,927 337,138 D: show line 2 in the form
Open-market sales · 15,625 sh · avg $37.56 · $586,927

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Fordyce Marshall PRESIDENT AND CEO 2024-08-14 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,625 858,587 D: show line 3 in the form
Loading xslF345X05/form4-08162024_080827.xml…